SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-044333
Filing Date
2024-04-05
Accepted
2024-04-05 16:57:50
Documents
10
Effectiveness Date
2024-04-05

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2410646d1_s8.htm S-8 46256
2 EXHIBIT 5.1 tm2410646d1_ex5-1.htm EX-5.1 9843
3 EX-FILING FEES tm2410646d1_ex-filingfees.htm EX-FILING FEES 14551
4 GRAPHIC tm2410646d1_ex5-1img002.jpg GRAPHIC 14697
5 GRAPHIC tm2410646d1_ex5-1img001.jpg GRAPHIC 23613
6 GRAPHIC tm2410646d1_ex5-1img003.jpg GRAPHIC 11985
7 EXHIBIT 23.2 tm2410646d1_ex23-2.htm EX-23.2 3048
8 GRAPHIC tm2410646d1_ex5-1img004.jpg GRAPHIC 5561
9 GRAPHIC tm2410646d1_ex23-2img002.jpg GRAPHIC 23683
10 GRAPHIC tm2410646d1_ex23-2img003.jpg GRAPHIC 8967
  Complete submission text file 0001104659-24-044333.txt   197660
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-278531 | Film No.: 24827236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)